Gelteq Ltd
GELS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001920092
No open-market purchases or sales by Gelteq Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.3K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Gelteq Ltd changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 0 | 3 | +3 |
| Shares | 0 | 80.9K | +80.9K |
| Value | $0 | $187.5K | +$187.5K |
New holders (3)
Institutions that held Gelteq Ltd at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wedbush Securities Inc | 51,000 | $118.0K | 0.00% |
| Citadel Advisors LLC | 23,748 | $55.1K | 0.00% |
| UBS Group AG | 6,199 | $14.4K | 0.00% |
Sold out (0)
Institutions that held Gelteq Ltd at the end of Q3 2024 and filed for Q4 2024 without it.
None.